User profiles for JEAN-LUC CRACOWSKI
Cracowski Jean-LucProfessor of Pharmacology Verified email at univ-grenoble-alpes.fr Cited by 12099 |
Methodological issues in the assessment of skin microvascular endothelial function in humans
JL Cracowski, CT Minson, M Salvat-Melis… - Trends in …, 2006 - cell.com
The study of microvascular function can be performed in humans using laser Doppler flowmetry
of the skin. This technology lends itself to a wide range of applications for studying the …
of the skin. This technology lends itself to a wide range of applications for studying the …
Non‐invasive assessment of skin microvascular function in humans: an insight into methods
M Roustit, JLUC CRACOWSKI - Microcirculation, 2012 - Wiley Online Library
… Jean-Luc Cracowski is MD, PhD, professor of Clinical Pharmacology at Grenoble University,
France. He is in charge of the Clinical Pharmacology Unit at the INSERM Clinical Research …
France. He is in charge of the Clinical Pharmacology Unit at the INSERM Clinical Research …
Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications
JL Cracowski, T Durand, G Bessard - Trends in pharmacological sciences, 2002 - cell.com
Isoprostanes are a complex family of compounds produced from arachidonic acid via a free-radical-catalyzed
mechanism. They can be quantified as reliable markers of lipid …
mechanism. They can be quantified as reliable markers of lipid …
Assessment of endothelial and neurovascular function in human skin microcirculation
M Roustit, JL Cracowski - Trends in pharmacological sciences, 2013 - cell.com
Peripheral microvascular dysfunction has been described in many physiological and pathological
conditions. Owing to its accessibility, the cutaneous microcirculation provides a unique …
conditions. Owing to its accessibility, the cutaneous microcirculation provides a unique …
Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies
…, S Cappelli, E Diot, A Vacca, JL Cracowski… - The Journal of …, 2010 - jrheum.org
Objective. To measure the prevalence of different types of pulmonary hypertension (PH) and
to identify patients with systemic sclerosis (SSc) at highest risk in a multicenter European …
to identify patients with systemic sclerosis (SSc) at highest risk in a multicenter European …
[HTML][HTML] The French health pass holds lessons for mandatory COVID-19 vaccination
…, E Botelho-Nevers, JL Cracowski… - Nature Medicine, 2022 - nature.com
The passe sanitaire increased levels of vaccination, but to a lower extent among the most
vulnerable, and did not reduce vaccine hesitancy itself, showing the importance of outreach …
vulnerable, and did not reduce vaccine hesitancy itself, showing the importance of outreach …
[HTML][HTML] Genome-Wide Scan Identifies TNIP1, PSORS1C1, and RHOB as Novel Risk Loci for Systemic Sclerosis
…, U Müller-Ladner, V Riccieri, B Ruiz, JL Cracowski… - PLoS …, 2011 - journals.plos.org
Systemic sclerosis (SSc) is an orphan, complex, inflammatory disease affecting the immune
system and connective tissue. SSc stands out as a severely incapacitating and life-…
system and connective tissue. SSc stands out as a severely incapacitating and life-…
Association of facial paralysis with mRNA COVID-19 vaccines: a disproportionality analysis using the World Health Organization pharmacovigilance database
…, J Perez, M Roustit, JL Cracowski - JAMA Internal …, 2021 - jamanetwork.com
Methods| Disproportionality analyses are hypothesisgenerating methods that aim to detect
putative associations between drugs and adverse drug reactions. Such methods quantify the …
putative associations between drugs and adverse drug reactions. Such methods quantify the …
Increased lipid peroxidation in patients with pulmonary hypertension
JL Cracowski, C Cracowski, G BESSARD… - American journal of …, 2001 - atsjournals.org
Isoprostanes are chemically stable lipid peroxidation products of arachidonic acid, the
quantification of which provides a novel approach to the assessment of oxidative stress in vivo. …
quantification of which provides a novel approach to the assessment of oxidative stress in vivo. …
Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials
…, PH Carpentier, E Caglayan, JL Cracowski - Annals of the …, 2013 - ard.bmj.com
Introduction Recent controlled trials have assessed the efficacy of phospodiesterase-5 (PDE-5)
inhibitors in secondary Raynaud's phenomenon (RP). However, the conclusions are …
inhibitors in secondary Raynaud's phenomenon (RP). However, the conclusions are …